Clinical Trial Update: Safety and Efficacy in Patients With Moderate to Severe Subacute and Chronic Atopic Dermatitis [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update evaluating safety and efficacy in moderate to severe subacute and chronic atopic dermatitis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atopic Dermatitis

Snippet

Sponsor: EHL Bio Co., Ltd. | Conditions: Atopic Dermatitis | Phase 2 | Status: ACTIVE_NOT_RECRUITING